[go: up one dir, main page]

CA2004478A1 - Anticorps monoclonaux contre le lentivirus t-lymphotrope felin - Google Patents

Anticorps monoclonaux contre le lentivirus t-lymphotrope felin

Info

Publication number
CA2004478A1
CA2004478A1 CA2004478A CA2004478A CA2004478A1 CA 2004478 A1 CA2004478 A1 CA 2004478A1 CA 2004478 A CA2004478 A CA 2004478A CA 2004478 A CA2004478 A CA 2004478A CA 2004478 A1 CA2004478 A1 CA 2004478A1
Authority
CA
Canada
Prior art keywords
feline
monoclonal antibodies
lymphotropic lentivirus
lymphotropic
lentivirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2004478A
Other languages
English (en)
Other versions
CA2004478C (fr
Inventor
Thomas P. O'connor
Quentin J. Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26960008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2004478(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Corp filed Critical Idexx Corp
Publication of CA2004478A1 publication Critical patent/CA2004478A1/fr
Application granted granted Critical
Publication of CA2004478C publication Critical patent/CA2004478C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002004478A 1988-12-05 1989-12-04 Anticorps monoclonaux contre le lentivirus t-lymphotrope felin Expired - Lifetime CA2004478C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27998988A 1988-12-05 1988-12-05
US293,906 1989-01-05
US279,989 1989-01-05
US07/293,906 US5219725A (en) 1988-12-05 1989-01-05 Monoclonal antibodies to feline-t-lymphotropic lentivirus

Publications (2)

Publication Number Publication Date
CA2004478A1 true CA2004478A1 (fr) 1990-06-05
CA2004478C CA2004478C (fr) 2000-02-15

Family

ID=26960008

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002004478A Expired - Lifetime CA2004478C (fr) 1988-12-05 1989-12-04 Anticorps monoclonaux contre le lentivirus t-lymphotrope felin

Country Status (8)

Country Link
US (5) US5219725A (fr)
EP (1) EP0446273B1 (fr)
JP (1) JP2893480B2 (fr)
AT (1) ATE172249T1 (fr)
CA (1) CA2004478C (fr)
DE (1) DE68928834T2 (fr)
ES (1) ES2124215T3 (fr)
WO (1) WO1990006510A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713286B2 (en) 1998-08-24 2004-03-30 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0471752A4 (en) * 1989-05-08 1992-09-02 Idexx Corp. Polypeptides of feline t-cell lymphotropic lentivirus
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
WO1992022573A1 (fr) * 1991-06-14 1992-12-23 St Vincent's Institute Of Medical Research Limited Detection des virus de l'immunodeficience chez les mammiferes
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
WO2000049049A1 (fr) 1999-02-19 2000-08-24 Michigan State University Test d'antigenes pour la detection de myeloencephalite protozoaire equine dans le serum et le liquide cephalorachidien equins
EP1074625A3 (fr) * 1999-06-14 2002-01-02 Pfizer Products Inc. ADN vaccin contre le virus de l'immunodéficience chez les félins
WO2002067984A2 (fr) * 2001-02-22 2002-09-06 University Of Florida Materiaux et methodes permettant de detecter, de prevenir et de traiter une infection retrovirale a vih ou a vif
US7345152B2 (en) * 2002-09-12 2008-03-18 Wyeth Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein
EP2107374A1 (fr) * 2003-09-11 2009-10-07 Idexx Laboratories, Inc. Polypeptide pour le diagnostic de vaccination
EP1709447B1 (fr) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Procede pour detecter le virus d'immunideficience feline
CA2556141A1 (fr) * 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Methode et dispositif de detection du virus de l'immunodeficience feline
CA2576902C (fr) * 2004-06-30 2012-05-08 Idexx Laboratories, Inc. Procede et appareil servant a detecter le virus de l'immunodeficience feline
CA2570610A1 (fr) * 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Procede et dispositif pour detecter un virus d'immunodeficience feline
AU2005267608B2 (en) * 2004-06-30 2009-01-15 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (FIV) comprising the use of peptides derived from the V3 region of the FIV env protein
US7291338B2 (en) * 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8936946B2 (en) * 2007-06-20 2015-01-20 Board Of Trustees Of Michigan State University Biologically enhanced electrically-active magnetic nanoparticles for concentration, separation, and detection applications
EP2553452B1 (fr) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Détection du virus de l'immunodéficience féline
US8859297B2 (en) 2011-05-23 2014-10-14 Board Of Trustees Of Michigan State University Detection of conductive polymer-labeled analytes
US10739337B2 (en) 2011-08-30 2020-08-11 Board Of Trustees Of Michigan State University Extraction and detection of pathogens using carbohydrate-functionalized biosensors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1777014A (en) * 1929-08-31 1930-09-30 Packard Testers Inc Egg tester
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
AU6713287A (en) 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
NZ220200A (en) 1986-05-19 1990-08-28 Viral Technologies Inc Hiv related peptides, antibodies to the peptides and vaccines therefrom
US5118602A (en) * 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
CA1341439C (fr) * 1987-08-26 2003-09-23 Niels C. Pedersen Lentivirus t-lymphotrope felin
US5177014A (en) * 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713286B2 (en) 1998-08-24 2004-03-30 Pfizer Inc. Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus

Also Published As

Publication number Publication date
ATE172249T1 (de) 1998-10-15
EP0446273B1 (fr) 1998-10-14
WO1990006510A1 (fr) 1990-06-14
JPH04502856A (ja) 1992-05-28
US5219725A (en) 1993-06-15
EP0446273A4 (en) 1992-07-08
DE68928834D1 (de) 1998-11-19
DE68928834T2 (de) 1999-04-29
CA2004478C (fr) 2000-02-15
US20050208481A1 (en) 2005-09-22
ES2124215T3 (es) 1999-02-01
US20020095027A1 (en) 2002-07-18
JP2893480B2 (ja) 1999-05-24
US6383765B1 (en) 2002-05-07
US5656732A (en) 1997-08-12
EP0446273A1 (fr) 1991-09-18

Similar Documents

Publication Publication Date Title
CA2004478A1 (fr) Anticorps monoclonaux contre le lentivirus t-lymphotrope felin
AU616156B2 (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
NZ219113A (en) Hiv peptide containing epitope of the env protein
EP0284587A3 (fr) Antigènes peptides synthétiques pour la détection d'infections de HIV-1
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
AU7345487A (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3330689A (en) Monoclonal antibodies
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
AU7068587A (en) Monoclonal antibody immunoblot assay for antigens
AU8944291A (en) Immunoassay for the determination of anti-hiv antibodies in human samples
AU5444386A (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
AU7087387A (en) Competitive elisa for the detection of antibodies
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
AU3829189A (en) Detecting antigens or antibodies
NO162210C (no) Monoklonale antistoffer mot c5a for in-vitro anvendelse ved immunologiske kvantitative teknikker eller ved isolering av c5a.
AU618720B2 (en) Monoclonal antibodies
AU2868489A (en) Assays for incipient diabetes, monoclonal antibodies used therein and kits for use therefor
AU3432389A (en) Human monoclonal antibodies against rabies virus

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202